Cargando…
The Use of 1α,25-Dihydroxyvitamin D(3) as an Anticancer Agent
The notion that vitamin D can influence the incidence of cancer arose from epidemiological studies. The major source of vitamin D in the organism is skin production upon exposure to ultra violet-B. The very first observation of an inverse correlation between exposure of individuals to the sun and th...
Autores principales: | Marcinkowska, Ewa, Wallace, Graham R., Brown, Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881551/ https://www.ncbi.nlm.nih.gov/pubmed/27187375 http://dx.doi.org/10.3390/ijms17050729 |
Ejemplares similares
-
Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D(2) as Potential Anti-Leukemic Agents
por: Corcoran, Aoife, et al.
Publicado: (2016) -
Expression of nephronectin is enhanced by 1α,25‐dihydroxyvitamin D(3)
por: Hiranuma, Katsuhiro, et al.
Publicado: (2016) -
The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model
por: Santucci, Kimberly L., et al.
Publicado: (2011) -
Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014) -
Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D(3) in response to disrupted fusion FOP2–FGFR1 gene in acute myeloid leukemia cells
por: Marchwicka, Aleksandra, et al.
Publicado: (2016)